Modern Healthcare Technology Holdings (HKG:919) First Half 2025 Results
Key Financial Results
- Revenue: HK$226.0m (up 6.3% from 1H 2024).
- Net loss: HK$16.3m (loss narrowed by 43% from 1H 2024).
- HK$0.018 loss per share (improved from HK$0.032 loss in 1H 2024).
All figures shown in the chart above are for the trailing 12 month (TTM) period
Modern Healthcare Technology Holdings shares are down 2.2% from a week ago.
Risk Analysis
It is worth noting though that we have found 4 warning signs for Modern Healthcare Technology Holdings (2 are significant!) that you need to take into consideration.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.